AXIM BIOTECHNOLOGIES, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, issued for services for the quarter ending 2022-03-31 was $79.50K, a 72.35% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, issued for services for the quarter ending 2021-12-31 was $1.89M, a 418.52% increase year-over-year.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, issued for services for the quarter ending 2021-09-30 was $1.11M, a 193.62% increase year-over-year.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, issued for services for the quarter ending 2021-06-30 was $776.50K.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, issued for services for fiscal 2023 was $80.08K, a 0.73% increase from fiscal 2022.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, issued for services for fiscal 2022 was $79.50K, a 95.79% decline from fiscal 2021.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, issued for services for fiscal 2021 was $1.89M, a 183.46% increase from fiscal 2020.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, issued for services for fiscal 2020 was $666.19K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2023-12-31 | $80.08K 10-K · filed 2024-04-16 | |
| 2022-12-31 | $79.50K 10-K · filed 2024-04-16 | |
| 2022-03-31 | $79.50K 10-Q · filed 2023-11-20 | $3.86M derived: sum of 4 quarters · filed 2023-11-20 |
| 2021-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $1.89M 10-K · filed 2023-04-17 |
| 2021-09-30 | $1.11M 10-Q/A · filed 2022-11-15 | $2.54M derived: sum of 4 quarters · filed 2022-11-15 |
| 2021-06-30 | $776.50K 10-Q/A · filed 2022-11-15 | $1.81M derived: sum of 4 quarters · filed 2022-11-15 |
| 2021-03-31 | $287.50K 10-Q/A · filed 2021-06-02 | |
| 2020-12-31 | $364.19K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-04-19 | $666.19K 10-K/A · filed 2022-04-19 |
| 2020-09-30 | $378.69K 10-Q · filed 2021-11-22 | |
| 2020-03-31 | $287.50K 10-Q · filed 2021-11-22 | |
| 2019-06-30 | $7.50K 10-Q/A · filed 2020-11-27 | |
| 2018-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-05-20 | $854.34K 10-K/A · filed 2020-05-20 |
| 2018-09-30 | $36.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $854.34K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-17 | $817.80K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-03-31 | $817.80K 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-08 | $31.80K 10-K · filed 2019-04-08 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | |
| 2016-12-31 | $706.20K 10-K · filed 2018-03-15 |